Dishman Carbogen Amcis Limited (DCAL.BO)
INR 274.5
(-3.18%)
INR 274.5
(-3.18%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -9.79 INR | -415.26% |
| 2022 | -1.90 INR | -265.22% |
| 2021 | 1.15 INR | 110.92% |
| 2020 | -10.53 INR | -206.9% |
| 2019 | 9.85 INR | -24.41% |
| 2018 | 13.03 INR | 36.01% |
| 2017 | 9.58 INR | 6.33% |
| 2016 | 9.01 INR | -15.0% |
| 2015 | 10.60 INR | 42.66% |
| 2014 | 7.43 INR | 9.75% |
| 2013 | 6.77 INR | 8.84% |
| 2012 | 6.22 INR | 76.7% |
| 2011 | 3.52 INR | -29.03% |
| 2010 | 4.96 INR | -31.87% |
| 2009 | 7.28 INR | -19.74% |
| 2008 | 9.07 INR | 15.54% |
| 2007 | 7.85 INR | 19.3% |
| 2006 | 6.58 INR | 77.84% |
| 2005 | 3.70 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -4.95 INR | -10.99% |
| 2023 Q4 | -4.46 INR | -17.37% |
| 2023 Q3 | -3.80 INR | -45.59% |
| 2023 FY | - INR | -415.26% |
| 2023 Q1 | 1.08 INR | 123.95% |
| 2023 Q2 | -2.61 INR | -341.67% |
| 2022 Q2 | -0.64 INR | -346.15% |
| 2022 Q1 | 0.26 INR | 109.15% |
| 2022 FY | - INR | -265.22% |
| 2022 Q4 | -4.51 INR | -250.33% |
| 2022 Q3 | 3.00 INR | 568.75% |
| 2021 Q1 | 1.02 INR | 111.85% |
| 2021 Q2 | 0.71 INR | -30.39% |
| 2021 Q3 | 2.26 INR | 218.31% |
| 2021 Q4 | -2.84 INR | -225.66% |
| 2021 FY | - INR | 110.92% |
| 2020 Q2 | 0.47 INR | 134.31% |
| 2020 Q3 | -1.02 INR | -317.02% |
| 2020 Q4 | -8.61 INR | -744.12% |
| 2020 Q1 | -1.37 INR | 0.0% |
| 2020 FY | - INR | -206.9% |
| 2019 Q3 | 2.04 INR | -20.0% |
| 2019 Q1 | 2.13 INR | 0.0% |
| 2019 FY | - INR | -24.41% |
| 2019 Q2 | 2.55 INR | 19.72% |
| 2019 Q4 | - INR | -100.0% |
| 2018 Q3 | 3.18 INR | 16.48% |
| 2018 FY | - INR | 36.01% |
| 2018 Q4 | - INR | -100.0% |
| 2018 Q2 | 2.73 INR | 10.98% |
| 2018 Q1 | 2.46 INR | -22.4% |
| 2017 Q2 | 3.00 INR | 270.37% |
| 2017 Q3 | 2.60 INR | -13.33% |
| 2017 Q4 | 3.17 INR | 21.92% |
| 2017 FY | - INR | 6.33% |
| 2017 Q1 | 0.81 INR | -69.43% |
| 2016 FY | - INR | -15.0% |
| 2016 Q4 | 2.65 INR | 31.84% |
| 2016 Q1 | 1.88 INR | 5.03% |
| 2016 Q2 | 2.37 INR | 26.06% |
| 2016 Q3 | 2.01 INR | -15.19% |
| 2015 Q4 | 1.79 INR | -35.38% |
| 2015 Q2 | 1.72 INR | -30.65% |
| 2015 Q1 | 2.48 INR | 0.0% |
| 2015 FY | - INR | 42.66% |
| 2015 Q3 | 2.77 INR | 61.05% |
| 2014 FY | - INR | 9.75% |
| 2014 Q4 | - INR | -100.0% |
| 2014 Q3 | 1.49 INR | -28.02% |
| 2014 Q2 | 2.07 INR | 39.86% |
| 2014 Q1 | 1.48 INR | 0.0% |
| 2013 Q2 | 2.62 INR | 44.75% |
| 2013 FY | - INR | 8.84% |
| 2013 Q4 | - INR | -100.0% |
| 2013 Q3 | 0.94 INR | -64.12% |
| 2013 Q1 | 1.81 INR | 0.0% |
| 2012 Q3 | 1.01 INR | -38.79% |
| 2012 Q4 | - INR | -100.0% |
| 2012 FY | - INR | 76.7% |
| 2012 Q2 | 1.65 INR | -31.25% |
| 2012 Q1 | 2.40 INR | 0.0% |
| 2011 Q3 | 1.03 INR | 0.0% |
| 2011 FY | - INR | -29.03% |
| 2011 Q4 | - INR | -100.0% |
| 2010 FY | - INR | -31.87% |
| 2009 FY | - INR | -19.74% |
| 2008 FY | - INR | 15.54% |
| 2007 FY | - INR | 19.3% |
| 2006 FY | - INR | 77.84% |
| 2005 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 0.09 INR | 11263.056% |
| Biocon Limited | 8.55 INR | 214.503% |
| Blue Jet Healthcare Limited | 9.44 INR | 203.708% |
| Concord Biotech Limited | 29.45 INR | 133.243% |
| FERMENTA BIOTECH LIMITED | -7.99 INR | -22.528% |
| GENOMIC VALLEY BIOTECH LIMITED | 0.05 INR | 19680.0% |
| Lyka Labs Limited | -0.82 INR | -1093.902% |
| Panacea Biotec Limited | -0.19 INR | -5052.632% |
| SAMSRITA LABS LIMITED | -0.18 INR | -5338.889% |
| Servoteach Industries Limited | -0.00 INR | -9789900.0% |
| SMS Lifesciences India Limited | 30.08 INR | 132.547% |
| Supriya Lifescience Limited | 14.80 INR | 166.149% |
| Syngene International Limited | 12.71 INR | 177.026% |
| TAKE Solutions Limited | -8.18 INR | -19.682% |
| Titan Biotech Limited | 30.07 INR | 132.557% |
| Transgene Biotek Limited | -0.09 INR | -10777.778% |
| Vanta Bioscience Limited | -3.67 INR | -166.757% |